Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: The antibody factor

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 2, 2010, Pages 137-141

  Gomez Fernandez, Carmen ^a   Mejias, Aldo ^a   Walker, Gail ^a   Nadji, Mehrdad ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen receptor; Immunohistochemistry; Pulmonary adenocarcinomas

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1D5; MONOCLONAL ANTIBODY 6F11; MONOCLONAL ANTIBODY SP1; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ANTIGEN RETRIEVAL; ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; RABBITS;

EID: 77649157230     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181bec23b     Document Type: Article

References (21)

1. Allred DC, Harvey JM, Berardo M, et al.. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155-168.
2. Harvey JM, Clark GM, Osborne CK, et al.. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy. J Clin Oncol. 1999;17:1474-1481.
3. Morani A, Warner M, Gustafsson J-A. Biological functions and clinical implications of estrogen receptors alpha and beta in epithelial tissues. J Int Med. 2008;264:128-142.
4. Zhao C, Dahlman-Wright K, Gustafsson J-A. Estrogen receptor beta: an overview and update. NRS. 2008;6:1-10.
5. Ali G, Donati V, Loggini B, et al.. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma. Hum Pathol. 2008;39:1465-1473.
6. Schwartz A, Prysak GM, Murphy V, et al.. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res. 2005;11:7280-7287.
7. Dabbs DJ, Landreneau RJ, Liu Y, et al.. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg. 2002;73:403-406.
8. Di Nunno L, Larsson LG, Rinehart JJ. Estrogen and progesterone receptors in non-small cell lung cancer in 258 consecutive patients who underwent surgical resection. Arch Pathol Lab Med. 2000;124: 1467-1470.
9. Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of estrogen receptor in pulmonary adenocarcinoma. Appl Immunohistochem Mol Morphol. 2006;14:83-87.
10. Ordonez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol. 2000;7:123-127.
11. Fleiss J, Levin B, Cho Paik M. Statistical Methods for Rates and Proportions. 3rd ed. Hoboken, NJ: Wiley; 2003.
12. Armitage P, Berry B, Mathews JNS. Statistical Methods in Medical Research. 4th ed. Oxford: Blackwell Scientific; 2002.
13. Pertschuk LP, Feldman JG, Kim Y-D, et al.. Estrogen receptor immunocytochemistry in paraffin embedded tissue with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays. Cancer. 1996;77:2514-2519.
14. Vassallo J, Pinto GA, Alvarenga M, et al.. Comparison of immunoexpression of 2 antibodies for estrogen receptors (1D5 and 6F11) in breast carcinomas using different antigen retrieval and detection methods. Appl Immunohistochem Mol Morphol. 2004;12: 177-182.
15. Nadji M, Gomez-Fernandez C, Ganjei-Azar P, et al.. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. Am J Clin Pathol. 2005;123: 21-27.
16. Collins LC, Botero ML, Schnitt SJ. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol. 2005;123:16-20.
17. Huang Z, Zhu W, Szekeres G, et al.. Development of new rabbit monoclonal antibody to estrogen receptor. Appl Immunohistochem Mol Morphol. 2005;13:91-95.
18. Cheang MCU, Treaba DO, Speer CH, et al.. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. JCO. 2006;24:5637-5644.
19. Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol and Cell Endocrinol. 2002;188:125-140.
20. Stabile LP, Gaither Davis AL, Gubish CT, et al.. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 2002;62:2141-2150.
21. Radzikowska E, Langfort R, Giedronowicz D. Estrogen and progesterone receptors in non-small cell lung cancer patients. Ann Thorac Cardiovasc Surg. 2002;8:69-73.